Literature DB >> 22044730

Novel scoring system as a useful model to predict the outcome of patients with acute liver failure: Application to indication criteria for liver transplantation.

Takafumi Naiki1, Nobuaki Nakayama, Satoshi Mochida, Makoto Oketani, Yasuhiro Takikawa, Kazuyuki Suzuki, Shin-Ichiro Tada, Takafumi Ichida, Hisataka Moriwaki, Hirohito Tsubouchi.   

Abstract

AIM: In Japan, the indication for liver transplantation in patients with acute liver failure (ALF) is currently determined according to the guideline published in 1996. However, its predictive accuracy has fallen in recent patients. Thus, we attempted to establish a new guideline.
METHODS: The subjects were 1096 ALF patients enrolled in a nationwide survey. All patients showed a prothrombin time <40% of the standardized value and grade II or more severe hepatic encephalopathy. A multiple logistic regression analysis and receiver operating characteristic analysis were performed in 698 patients seen between 1998 and 2003 to identify significant parameters determining the outcome of patients. The extracted parameters were graded as numerical scores. An established scoring system was validated in patients seen between 2004 and 2008.
RESULTS: Six parameters were identified and graded as 0, 1 and/or 2; the interval between disease onset and development of hepatic encephalopathy, prothrombin time, serum total bilirubin concentration, the ratio of direct to total bilirubin concentration, peripheral platelet count and the presence of liver atrophy. When the prognosis of the patients with total score of 5 or more was judged as "death", the predictive accuracy was 0.80 with sensitivity, specificity, positive predictive value and negative predictive value greater than 0.70. The values were similarly high in patients for validation.
CONCLUSION: Novel scoring system for predicting the outcome of ALF patients may be useful to determine the indication of liver transplantation, since the system showed high predictive accuracy even after validation.
© 2011 The Japan Society of Hepatology.

Entities:  

Year:  2011        PMID: 22044730     DOI: 10.1111/j.1872-034X.2011.00902.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  9 in total

1.  Serum Procalcitonin in Patients with Acute Liver Failure.

Authors:  Takaaki Sugihara; Masahiko Koda; Toshiaki Okamoto; Kenichi Miyoshi; Tomomitsu Matono; Kenji Oyama; Keiko Hosho; Jun-Ichi Okano; Hajime Isomoto
Journal:  Yonago Acta Med       Date:  2017-03-09       Impact factor: 1.641

2.  Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury.

Authors:  Kei Morio; Michio Imamura; Kana Daijo; Yuji Teraoka; Fumi Honda; Yuki Nakamura; Tomoki Kobayashi; Takashi Nakahara; Yuko Nagaoki; Tomokazu Kawaoka; Masataka Tsuge; Akira Hiramatsu; Yoshiiku Kawakami; Hiroshi Aikata; Clair Nelson Hayes; Kazuko Tsugawa; Michiya Yokozaki; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2017-05-05       Impact factor: 7.527

3.  Successful living donor liver transplantation for acute liver failure after acetylsalicylic acid overdose.

Authors:  Tomoki Shirota; Toshihiko Ikegami; Satoshi Sugiyama; Kouji Kubota; Akira Shimizu; Yasunari Ohno; Atsuyoshi Mita; Koichi Urata; Yuichi Nakazawa; Akira Kobayashi; Mai Iwaya; Shinichi Miyagawa
Journal:  Clin J Gastroenterol       Date:  2015-02-25

Review 4.  Acute and acute severe (fulminant) autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-10-23       Impact factor: 3.199

5.  Evaluation of the prognosis of fulminant viral hepatitis in late pregnancy by the MELD scoring system.

Authors:  Y Yang; L Deng; X Li; Z Shi; D Chen; X Chen; M Li; L Ma
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-09       Impact factor: 3.267

6.  Liver Fibrosis Markers Improve Prediction of Outcome in Non-Acetaminophen-Associated Acute Liver Failure.

Authors:  Aya Ugamura; Po-Sung Chu; Nobuhiro Nakamoto; Nobuhito Taniki; Keisuke Ojiro; Taizo Hibi; Masahiro Shinoda; Hideaki Obara; Yohei Masugi; Akihiro Yamaguchi; Shunsuke Shiba; Rei Morikawa; Shingo Usui; Hirotoshi Ebinuma; Yuko Kitagawa; Hidetsugu Saito; Takanori Kanai
Journal:  Hepatol Commun       Date:  2018-09-21

7.  Analysis of the safety of pretransplant corticosteroid therapy in patients with acute liver failure and late-onset hepatic failure in Japan.

Authors:  Takuro Hisanaga; Isao Hidaka; Isao Sakaida; Nobuaki Nakayama; Akio Ido; Naoya Kato; Yasuhiro Takikawa; Kazuaki Inoue; Masahito Shimizu; Takuya Genda; Shuji Terai; Hirohito Tsubouchi; Hajime Takikawa; Satoshi Mochida
Journal:  JGH Open       Date:  2021-03-05

8.  Fulminant Hepatitis due to de novo Hepatitis B after Cord Blood Transplantation Rescued by Medical Treatment.

Authors:  Tomoya Sano; Norio Akuta; Yoshiyuki Suzuki; Kayoko Kasuya; Shunichiro Fujiyama; Yusuke Kawamura; Hitomi Sezaki; Tetsuya Hosaka; Satoshi Saitoh; Masahiro Kobayashi; Fumitaka Suzuki; Mariko Kobayashi; Yasuji Arase; Kenji Ikeda; Hiromitsu Kumada
Journal:  Intern Med       Date:  2020-06-15       Impact factor: 1.271

9.  Contrast-Enhanced Ultrasonography-Based Hepatic Perfusion for Early Prediction of Prognosis in Acute Liver Failure.

Authors:  Hidekatsu Kuroda; Tamami Abe; Yudai Fujiwara; Tomoaki Nagasawa; Yuji Suzuki; Keisuke Kakisaka; Yasuhiro Takikawa
Journal:  Hepatology       Date:  2021-05-24       Impact factor: 17.425

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.